Everything below concerns DAC. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-04-10. Where a claim depends on a specific study, the study is described rather than over-claimed.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
| Property | Value | Notes |
|---|---|---|
| Primary target | GHRH receptor | Present on pituitary somatotroph cells |
| Signal pathway | Gs, cyclic AMP, protein kinase A | Sequence follows receptor activation |
| Main measured effect | Growth hormone release | Insulin-like growth factor 1 shifts indirectly |
| Half-life, binding form | Several days | Extended through serum albumin association |
| Half-life, unmodified form | About 30 minutes | Limited mainly by enzymatic cleavage |
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
Reverse-phase high-performance liquid chromatography is the standard tool for purity assessment. The technique separates the target peptide from truncated or modified byproducts. Mass spectrometry confirms molecular weight and supports sequence verification. Electrospray ionization and matrix-assisted laser desorption are both used. Amino acid analysis provides an independent check on composition. Purity values are commonly reported as area percentage from the chromatogram. Residual trifluoroacetate and water content are also measured in many quality programs.
Batch-to-batch consistency depends on solid-phase peptide synthesis and subsequent purification. Coupling efficiency, resin choice, and cleavage conditions all affect the final profile. Counter-ion content and moisture can shift the apparent mass of a batch. Documentation typically includes a certificate of analysis with chromatograms and spectra. Independent verification by a second laboratory is sometimes requested. Whether a given certificate reflects the actual vial contents depends on chain of custody. Analytical methods themselves carry uncertainty that should be stated alongside results.
Pyruvate formate-lyase activating enzyme (PFL-AE) catalyzes the activation of PFL, a central enzyme in anaerobic glucose metabolism in microbes. Benzylsuccinate synthase (BSS) is a central enzyme in anaerobic toluene catabolism.
The densities of the two phases must also be sufficiently different so that the phases will move past each other in the column. Many DCCC solvent systems contain both chloroform and water. The solvent system used in the seminal publication was made from chloroform, acetic acid, and aqueous 0.1 M hydrochloric acid. Many subsequent solvents systems were made with chloroform, methanol, and water which is sometimes represented as a ChMWat solvent system. Solvent systems formulated with ''n''-butanol, water and a modifier such as acetic acid, pyridine or n-propanol have also enjoyed some success in DCCC. In some cases, non-aqueous biphasic solvent systems such as acetonitrile and methanol have been utilized. The main difference between DCCC and other types of countercurrent chromatography techniques is that there is no vigorous mixing of phases to enhance the mass transfer of compounds that allows them to distribute between the two phases. In 1951 Kies and Davis described an apparatus similar to the DCCC. They created a series of open tubes that were arranged in a cascade to either drip a more dense phase through a less dense stationary phase or, conversely, a less dense phase could be introduced into the bottom of the tube to dribble through the more dense phase. In 1954, a fractionation column was introduced by Kepes the resembled a CCC column divided into chambers with perforated plastic disks. Similar DCCC-type instruments have been created by A. E. Kostanyan and collaborators which employ vertical columns that are divided into partitions with porous disks.
Minister of Foreign Affairs Paulo Rangel confirmed that the Portuguese government is continuously monitoring the situation in Venezuela, in coordination with the President of the Republic, through the Portuguese embassy in Caracas, the consular network and contacts with European partners, the European Union and countries in the region. The Portuguese government has declared the safety of Portuguese nationals in Venezuela to be a priority. Romania: Prime Minister Ilie Bolojan stated that "Without being an international law specialist, obviously following the relations between the United States and Venezuela, they have been conflictual relations for many years, with the United States accusing the dictatorial leaderships of Venezuela in recent years of drug trafficking, of encouraging crime, of illegal migration and the United States Navy has been in the Venezuelan coastal area and is hitting boats that are suspected of drug trafficking. From this point of view, it was certainly a special operation that is not usual, but I hope the people of Venezuela will be in a situation where they will manage to establish a stable leadership and return to a democratic system." Russia: The Ministry of Foreign Affairs condemned the strikes, calling them an "act of armed aggression". Serbia: President Aleksandar Vučić stated that "we want friendly relations with the United States, [...] but that it is our job to point out that there was a breach on international law".
Sources: en.wikipedia.org
Non-Somali ethnic minority groups make up the remainder of Somalia's population, and are largely concentrated in the southern regions. The Bantus, the largest ethnic minority group in Somalia, are the descendants of slaves brought from southeastern Africa by Arab and Somali traders. In 1940, there were about 50,000 Italians living in Italian Somaliland, although most Europeans left after independence. A sizeable Somali diaspora exists in various Western countries, the Arabian peninsula, and several African nations. The Somali diaspora is involved in the politics and development of Somalia. Somalia's population is expanding at a growth rate of 1.75% per annum and a birth rate of 40.87 births per 1,000 people. The total fertility rate of Somalia is 6.08 children born per woman (2014 estimates), the fourth highest in the world, according to the CIA World Factbook. Most local residents are young, with a median age of 17.7 years; about 44% of the population is between the ages of 0–14 years, 52% is between the ages of 15–64 years, and only 2% is 65 years of age or older. The gender ratio is roughly balanced, with about as many men as women. There is little reliable statistical information on urbanisation in Somalia. Rough estimates have been made indicating a rate of urbanisation of 4.8% per annum (2005–2010 est.), with many towns quickly growing into cities. Many ethnic minorities have also moved from rural areas to urban centres since the onset of the civil war, particularly to Mogadishu and Kismayo. According to the World Bank, the urban population stood at 55% in 2024.
=== Regional cuisines === Chilies are present in many cuisines, including curries. In Peru, Papa a la huancaina is a dish of potatoes in a sauce of fresh cheese and aji amarillo chilies. In Thailand, kaeng tai pla fish curry is flavoured with a tai pla sauce made with garlic, shallots, galangal, kaffir lime, turmeric, fish paste, and bird's eye chilies. In Jamaica, jerk chicken is spiced with powerful habanero chilies and allspice. Goan vindaloo curry uses the extremely hot ghost pepper or bhut jolokia to create "perhaps [India's] hottest dish". In Bhutan, ema datshi, entirely made of chili mixed with local cheese, is the national dish. Many Mexican dishes use chilies of different types, including the jalapeño, poblano, habanero, serrano, chipotle, ancho, pasilla, guajillo, de árbol, cascabel and mulato. These offer a wide range of flavours including citrus, earthy, fruity, and grassy. They are used in many dishes and the spicy mole sauce and Mexican salsa sauces. In Yoruba cuisine, chillies are well used in many dishes including Ewa Agoyin and Obe ata.
Plasma levels of progesterone are similar after vaginal and rectal administration in spite of the different routes of administration, and rectal administration is an alternative to vaginal progesterone in conditions of vaginal infection, cystitis, recent childbirth, or when barrier contraception methods are used. Intramuscular injection of progesterone may achieve much higher levels of progesterone than normal luteal phase concentrations and levels achieved with other routes.
Sources: en.wikipedia.org
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.
It links the peptide to serum albumin after administration, which delays removal from circulation. Reported half-life shifts from roughly half an hour to several days as a result.
Most published work tracks serum growth hormone and insulin-like growth factor 1 over time. Sampling schedules and assay methods vary enough that figures are not directly comparable across reports.
No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.